Basic Study
Copyright ©The Author(s) 2024.
World J Gastrointest Oncol. Jul 15, 2024; 16(7): 3270-3283
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.3270
Figure 5
Figure 5 Overexpression of methyltransferase-like protein 14 inhibits the activation of PI3K/AKT pathway and gastric cancer progression. A and B: After methyltransferase-like protein 14 (METTL14) overexpression, the related protein levels were checked by Western blot, including METTL14, p-PI3K, PI3K, p-AKT, AKT, N-cadherin, Vimentin, ZEB1, MMP2, and MMP9, all normalized to β-actin; C: Cell viability was detected by cell counting kit-8 assay; D and E: Cell migration was detected by wound healing assay. aP < 0.05, bP < 0.01, compared with Hp27 + pcDNA3.1(+) group. METTL14: Methyltransferase-like protein 14.